Advancing Antibody–Drug Conjugates: Precision Oncology Approaches for Breast and Pancreatic Cancers is a research paper published in Cancers (2025). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health/National Cancer Institute
Grant: R01CA246182-01A1
National Institutes of Health/National Cancer Institute
Grant: R21CA273779
National Institutes of Health/National Cancer Institute
Grant: U54CA283762
NIH HHS
Grant: 5R01CA246182-05A1
NIH HHS
Grant: 5R21CA283762-02A1
NIH HHS
Grant: 5U54CA283762-02S1
NCI NIH HHS
Grant: R01 CA246182
National Institutes of Health
Grant: 5R21CA273779-02
Characterization of metastasis models derived from breast cancer patients of African descent
National Institutes of Health
Grant: 3R01CA246182-04S1
Circumventing acquired carboplatin resistance in triple-negative breast cancers
FWCI
4.43
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords